SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 8.25% growth in the revenue at Rs. 554.51 millions for the quarter ended March 2023 as compared to Rs. 512.27 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 1624.00% to Rs. 56.03  millions  from Rs. 3.25 millions in previous same quarter.Operating profit for the quarter ended March 2023 rose to 79.96 millions as compared to 11.49 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 554.51 512.27 8.25 2367.14 2175.84 8.79 2367.14 2175.84 8.79
Other Income 25.59 3.67 597.28 57.34 34.27 67.32 57.34 34.27 67.32
PBIDT 79.96 11.49 595.91 398.85 284.55 40.17 398.85 284.55 40.17
Interest 1.96 0.58 237.93 4.13 2.85 44.91 4.13 2.85 44.91
PBDT 78.00 10.91 614.94 360.13 281.70 27.84 360.13 281.70 27.84
Depreciation 4.79 6.45 -25.74 12.05 15.26 -21.04 12.05 15.26 -21.04
PBT 73.21 4.46 1541.48 348.08 266.44 30.64 348.08 266.44 30.64
TAX 17.18 1.21 1319.83 80.87 77.87 3.85 80.87 77.87 3.85
Deferred Tax 1.79 1.16 54.31 4.56 3.84 18.75 4.56 3.84 18.75
PAT 56.03 3.25 1624.00 267.21 188.57 41.70 267.21 188.57 41.70
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 14.42 2.24 542.88 16.85 13.08 28.84 16.85 13.08 28.84

Jagsonpal Pharma Share Price

192.80 -0.85 (-0.44%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×